FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Macleods Pharma Telmisartan and Hyrdochlorothiazide Tablets Recall

Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Man…

Macleods Pharma Usa Inc · Plainsboro, NJ

Risk level
Class II
Reported by FDA
Mar 20, 2019
Recall ID
D-1005-2019
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Telmisartan and Hyrdochlorothiazide Tablets starting Feb 25, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1005-2019 on Mar 20, 2019. Reason: Failed Content Uniformity Specifications: The product is out of specification for blend uniformity. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.

Product description

Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-130-07

Lot numbers, UPCs & expiration codes

Lot #: BTN703A, BTN704A Exp Feb-19; BTN705A, BTN706A, Exp May-19; BTN707A, Exp Jun-19; BTN810A, Exp Jun-20; BTN811A, BTN812A Exp Aug-20; BTN813A, BTN814A, Exp Sep-20; BTN802A, BTN802B, BTN803A, BTN804A, Exp Dec-19; BTN805A, BTN806A, BTN807A, BTN807B, Exp Feb-20; BTN808A, Exp Apr-20; BTN809A, BTN810A, Exp Jun-20; BTN811A, BTN812A, Exp Aug-20; BTN813A, BTN814A, Exp Sep-20.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1005-2019
Classification
Class II
Status
Terminated
Recall initiated
Feb 25, 2019
FDA report date
Mar 20, 2019
Quantity
134495 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Macleods Pharma Usa Inc

Original FDA data

Every field from FDA enforcement report D-1005-2019, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
82196
Address
666 Plainsboro Rd Bldg 200 Ste 230
Code information
Lot #: BTN703A, BTN704A Exp Feb-19; BTN705A, BTN706A, Exp May-19; BTN707A, Exp Jun-19; BTN810A, Exp Jun-20; BTN811A, BTN812A Exp Aug-20; BTN813A, BTN814A, Exp Sep-20; BTN802A, BTN802B, BTN803A, BTN804A, Exp Dec-19; BTN805A, BTN806A, BTN807A, BTN807B, Exp Feb-20; BTN808A, Exp Apr-20; BTN809A, BTN810A, Exp Jun-20; BTN811A, BTN812A, Exp Aug-20; BTN813A, BTN814A, Exp Sep-20.
Postal code
08536-0009
Report date
Mar 20, 2019
Product type
Drugs
Recall number
D-1005-2019
Classification
Class II
Recalling firm
Macleods Pharma Usa Inc
Product quantity
134495 bottles
Termination date
Jul 12, 2021
Reason for recall
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-130-07
Distribution pattern
Nationwide within the United States
Recall initiation date
Feb 25, 2019
Initial firm notification
Letter
Center classification date
Mar 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1005-2019, published Mar 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls